Mechanistic description
The ad_genetic_risk_loci dataset identifies PLCG2 rs72824905 as a rare protective AD variant with a strong protective odds-ratio proxy. The notebook’s Enrichr and GTEx analysis places PLCG2 in a microglial immune signaling module with actionable phospholipase biology. Hypothesis: partial, pathway-biased PLCG2 activation can increase microglial plaque and debris clearance while avoiding broad inflammatory gain-of-function toxicity.
Mechanism / pathway
- PLCG2
- microglial phospholipase signaling
- Alzheimer's disease
Evidence for (7)
PLCG2 rs72824905 is a protective rare variant in AD with OR around 0.32 in the curated notes.
PLCG2 ranked high on druggability due to protective human genetics, phospholipase biology, and immune-cell expression context.
Genetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease.
The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model.
PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology.
Alzheimer's disease-associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell-derived microglia-like cells.
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Evidence against (1)
Protective genetics do not define the safe activation window; inflammatory gain-of-function alleles create toxicity risk.
Evidence matrix
Supporting
- PLCG2 rs72824905 is a protective rare variant in AD with OR around 0.32 in the curated notes. dataset:ad_genetic_risk_loci
- PLCG2 ranked high on druggability due to protective human genetics, phospholipase biology, and immune-cell expression context. notebook:gwas-ad-risk-loci-analysis
- Genetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease. PMID:37659412 · 2023 · Immunity
- The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model. PMID:35142046 · 2022 · Alzheimers Dement
- PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology. PMID:40346446 · 2025 · Alzheimers Dement
- Alzheimer's disease-associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell-derived microglia-like cells. PMID:41066163 · 2025 · Alzheimers Dement
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. PMID:28714976 · 2017 · Nat Genet
Contradicting
- Protective genetics do not define the safe activation window; inflammatory gain-of-function alleles create toxicity risk. notebook:gwas-ad-risk-loci-analysis
Bayesian persona consensus
scidex.consensus.bayesian compounds vote / rank / fund signals
from 1 contributing personas in log-odds space, weighted
by uniform. Prior 50%.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Calibrated PLCG2 activation can reproduce the protective rs72824905 microglial…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-gwas-plcg2-protective-mimicry-5dee99f5
@misc{scidex_hypothesis_hgwasplc,
title = {Calibrated PLCG2 activation can reproduce the protective rs72824905 microglial…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-gwas-plcg2-protective-mimicry-5dee99f5},
note = {SciDEX artifact hypothesis:h-gwas-plcg2-protective-mimicry-5dee99f5}
}